Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 821

1.

Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer.

Verma V, Hasan S, Wegner RE, Abel S, Colonias A.

Radiother Oncol. 2019 Feb;131:145-149. doi: 10.1016/j.radonc.2018.12.006. Epub 2018 Dec 31.

PMID:
30773182
2.

Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria.

Ryckman JM, Appiah AK, Lyden E, Verma V, Zhang C.

Am J Clin Oncol. 2019 Feb 12. doi: 10.1097/COC.0000000000000519. [Epub ahead of print]

PMID:
30768441
3.

Microtubule plus-ends act as physical signaling hubs to activate RhoA during cytokinesis.

Verma V, Maresca TJ.

Elife. 2019 Feb 13;8. pii: e38968. doi: 10.7554/eLife.38968. [Epub ahead of print]

4.

Management of local anaesthetic systemic toxicity by timely lipid resuscitation in a paraturient - A case report.

Singh S, Lalin D, Verma VK.

Indian J Anaesth. 2019 Jan;63(1):68-70. doi: 10.4103/ija.IJA_574_18. No abstract available.

5.

Immunotherapy in extensive small cell lung cancer.

Verma V, Sharma G, Singh A.

Exp Hematol Oncol. 2019 Feb 4;8:5. doi: 10.1186/s40164-019-0129-x. eCollection 2019. Review.

6.

Ferrites: magnetic materials as an alternate source of green electrical energy.

Kharbanda P, Madaan T, Sharma I, Vashishtha S, Kumar P, Chauhan A, Mittal S, Bangruwa JS, Verma V.

Heliyon. 2019 Jan 24;5(1):e01151. doi: 10.1016/j.heliyon.2019.e01151. eCollection 2019 Jan.

7.

Patterns of Care in Pediatric Craniopharyngioma: Outcomes Following Definitive Radiotherapy.

Hill TK, Baine MJ, Verma V, Alam M, Lyden ER, Lin C, Connolly EP, Zhang C.

Anticancer Res. 2019 Feb;39(2):803-807. doi: 10.21873/anticanres.13178.

PMID:
30711960
8.

Neoadjuvant denosumab.

Puri A, Gulia A, Hegde P, Verma V, Rekhi B.

Bone Joint J. 2019 Feb;101-B(2):170-177. doi: 10.1302/0301-620X.101B2.BJJ-2018-0907.R2.

PMID:
30700112
9.

Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.

Foster CC, Sher DJ, Rusthoven CG, Verma V, Spiotto MT, Weichselbaum RR, Koshy M.

Radiat Oncol. 2019 Jan 28;14(1):18. doi: 10.1186/s13014-019-1222-3.

10.

Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.

Jiang W, Haque W, Verma V, Butler B, Teh BS.

Acta Oncol. 2019 Jan 24:1-8. doi: 10.1080/0284186X.2018.1562207. [Epub ahead of print]

PMID:
30676131
11.

Role of MAPK/NF-κB pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats.

Verma VK, Malik S, Narayanan SP, Mutneja E, Sahu AK, Bhatia J, Arya DS.

Mol Biol Rep. 2019 Jan 21. doi: 10.1007/s11033-018-04575-9. [Epub ahead of print]

PMID:
30666500
12.

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.

Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY.

JAMA Netw Open. 2018 Aug 3;1(4):e181390. doi: 10.1001/jamanetworkopen.2018.1390.

13.

Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer.

Haque W, Verma V, Butler EB, Teh BS, Rusthoven CG.

Lung Cancer. 2019 Jan;127:76-83. doi: 10.1016/j.lungcan.2018.11.026. Epub 2018 Nov 23.

PMID:
30642556
14.

Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States.

Verma V, Haque W, Cushman TR, Lin C, Simone CB 2nd, Chang JY, McClelland S 3rd, Welsh JW.

J Immunother. 2019 Feb/Mar;42(2):55-64. doi: 10.1097/CJI.0000000000000253.

PMID:
30628924
15.

Hesperidin regresses cardiac hypertrophy by virtue of PPAR-γ agonistic, anti-inflammatory, antiapoptotic, and antioxidant properties.

Bhargava P, Verma VK, Malik S, Khan SI, Bhatia J, Arya DS.

J Biochem Mol Toxicol. 2019 Jan 8:e22283. doi: 10.1002/jbt.22283. [Epub ahead of print]

PMID:
30623541
16.

Implication of embolization in residual disease in lateral extension of juvenile nasopharyngeal angiofibroma.

Mishra A, Verma V.

J Oral Biol Craniofac Res. 2019 Jan-Mar;9(1):115-118. doi: 10.1016/j.jobcr.2018.12.001. Epub 2018 Dec 2.

17.

A laboratory simulation study on suppression of resistance genes by differential exposures to an insecticide in Anopheles stephensi Liston population.

Verma V, Agrawal OP, Velamuri PS, Raghavendra K.

J Vector Borne Dis. 2018 Jul-Sep;55(3):184-188. doi: 10.4103/0972-9062.249126.

18.

Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.

Ryckman JM, Surkar SM, Haque W, Butler EB, Teh BS, Verma V.

Am J Clin Oncol. 2018 Dec 27. doi: 10.1097/COC.0000000000000511. [Epub ahead of print]

PMID:
30601146
19.

Complexation of Iron and Copper in Ambient Particulate Matter and Its Effect on the Oxidative Potential Measured in a Surrogate Lung Fluid.

Wei J, Yu H, Wang Y, Verma V.

Environ Sci Technol. 2019 Feb 5;53(3):1661-1671. doi: 10.1021/acs.est.8b05731. Epub 2019 Jan 11.

PMID:
30589257
20.

Current scenario of artemisinin and its analogues for antimalarial activity.

Kumari A, Karnatak M, Singh D, Shankar R, Jat JL, Sharma S, Yadav D, Shrivastava R, Verma VP.

Eur J Med Chem. 2019 Feb 1;163:804-829. doi: 10.1016/j.ejmech.2018.12.007. Epub 2018 Dec 13. Review.

PMID:
30579122
21.

Stem cell niche: Dynamic neighbor of stem cells.

Singh A, Yadav CB, Tabassum N, Bajpeyee AK, Verma V.

Eur J Cell Biol. 2018 Dec 12. pii: S0171-9335(18)30263-2. doi: 10.1016/j.ejcb.2018.12.001. [Epub ahead of print] Review.

PMID:
30563738
22.

Synthesis of quinazoline-3-oxides via a Pd(ii) catalyzed azide-isocyanide coupling/cyclocondensation reaction.

Pathare RS, Maurya AK, Kumari A, Agnihotri VK, Verma VP, Sawant DM.

Org Biomol Chem. 2019 Jan 2;17(2):363-368. doi: 10.1039/c8ob02627k.

PMID:
30556560
23.

The Sommerfeld ground-wave limit for a molecule adsorbed at a surface.

Chen L, Lau JA, Schwarzer D, Meyer J, Verma VB, Wodtke AM.

Science. 2019 Jan 11;363(6423):158-161. doi: 10.1126/science.aav4278. Epub 2018 Dec 13.

PMID:
30545846
24.

Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.

Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH.

Cell Mol Gastroenterol Hepatol. 2019;7(1):197-209. doi: 10.1016/j.jcmgh.2018.09.005. Epub 2018 Sep 15.

25.

Functional characterization of LIKE HETEROCHROMATIN PROTEIN 1 in the moss Physcomitrella patens: its conserved protein interactions in land plants.

Parihar V, Arya D, Walia A, Tyagi V, Dangwal M, Verma V, Khurana R, Boora N, Kapoor S, Kapoor M.

Plant J. 2019 Jan;97(2):221-239. doi: 10.1111/tpj.14182. Epub 2019 Jan 12.

PMID:
30537172
26.

SUMO conjugation to the pattern recognition receptor FLS2 triggers intracellular signalling in plant innate immunity.

Orosa B, Yates G, Verma V, Srivastava AK, Srivastava M, Campanaro A, De Vega D, Fernandes A, Zhang C, Lee J, Bennett MJ, Sadanandom A.

Nat Commun. 2018 Dec 5;9(1):5185. doi: 10.1038/s41467-018-07696-8.

27.

Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.

Cushman TR, Shaaban SG, Moreno AC, Lin C, Verma V.

Am J Clin Oncol. 2019 Feb;42(2):154-159. doi: 10.1097/COC.0000000000000499.

PMID:
30499838
28.

Production and purification of an alkaline lipase from Bacillus sp. for enantioselective resolution of (±)-Ketoprofen butyl ester.

Saraswat R, Bhushan I, Gupta P, Kumar V, Verma V.

3 Biotech. 2018 Dec;8(12):491. doi: 10.1007/s13205-018-1506-6. Epub 2018 Nov 19.

PMID:
30498664
29.

Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.

Haque W, Arms A, Verma V, Hatch S, Brian Butler E, Teh BS.

Breast. 2019 Feb;43:67-73. doi: 10.1016/j.breast.2018.11.007. Epub 2018 Nov 21.

PMID:
30496936
30.

Water in Rechargeable Multivalent-Ion Batteries: An Electrochemical Pandora's Box.

Manalastas W Jr, Kumar S, Verma V, Zhang L, Yuan D, Srinivasan M.

ChemSusChem. 2019 Jan 24;12(2):379-396. doi: 10.1002/cssc.201801523. Epub 2019 Jan 7. Review.

PMID:
30480870
31.

Medical leadership competencies: A comparative study of physicians in public and private sector hospitals in India.

Gulati K, Madhukar V, Verma V, Singh AR, Gupta SK, Sarkar C.

Int J Health Plann Manage. 2018 Nov 27. doi: 10.1002/hpm.2709. [Epub ahead of print]

PMID:
30480333
32.

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

Verma V, Sprave T, Haque W, Simone CB 2nd, Chang JY, Welsh JW, Thomas CR Jr.

J Immunother Cancer. 2018 Nov 23;6(1):128. doi: 10.1186/s40425-018-0442-7. Review.

33.

Molecular dynamics analysis of the effects of GTP, GDP, and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from Mycobacterium tuberculosis.

Hakeem S, Singh I, Sharma P, Uppal A, Khajuria Y, Verma V, Uversky VN, Chandra R.

J Biomol Struct Dyn. 2018 Nov 22:1-25. doi: 10.1080/07391102.2018.1548979. [Epub ahead of print]

PMID:
30466358
34.

Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.

Verma V, Ahern CA, Berlind CG, Lindsay WD, Grover S, Friedberg JS, Simone CB 2nd.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):758-766.e1. doi: 10.1016/j.jtcvs.2018.10.039. Epub 2018 Oct 22.

PMID:
30454981
35.

Optically Addressing Single Rare-Earth Ions in a Nanophotonic Cavity.

Zhong T, Kindem JM, Bartholomew JG, Rochman J, Craiciu I, Verma V, Nam SW, Marsili F, Shaw MD, Beyer AD, Faraon A.

Phys Rev Lett. 2018 Nov 2;121(18):183603. doi: 10.1103/PhysRevLett.121.183603.

PMID:
30444379
36.

Activity Monitoring with a Wrist-Worn, Accelerometer-Based Device.

Lin WY, Verma VK, Lee MY, Lai CS.

Micromachines (Basel). 2018 Sep 10;9(9). pii: E450. doi: 10.3390/mi9090450.

37.

ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma.

Cushman TR, Verma V, Simone CB 2nd.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):767-768. doi: 10.1245/s10434-018-7021-5. Epub 2018 Nov 12. No abstract available.

PMID:
30421065
38.

Demonstration of Einstein-Podolsky-Rosen Steering Using Hybrid Continuous- and Discrete-Variable Entanglement of Light.

Cavaillès A, Le Jeannic H, Raskop J, Guccione G, Markham D, Diamanti E, Shaw MD, Verma VB, Nam SW, Laurat J.

Phys Rev Lett. 2018 Oct 26;121(17):170403. doi: 10.1103/PhysRevLett.121.170403.

PMID:
30411932
39.

National Cancer Database report of nonmetastatic esophageal small cell carcinoma.

Verma V, Sleightholm RL, Fang P, Ryckman JM, Lin C.

Cancer Med. 2018 Dec;7(12):6365-6373. doi: 10.1002/cam4.1712. Epub 2018 Nov 6.

40.

Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy.

Verma V, Chang JY.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S280-S282. doi: 10.21037/tlcr.2018.04.08. No abstract available.

41.

Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.

Kann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH.

Radiother Oncol. 2018 Oct 31. pii: S0167-8140(18)33541-2. doi: 10.1016/j.radonc.2018.10.017. [Epub ahead of print]

PMID:
30391106
42.

Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.

Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, Bostel T, El Shafie RA, Welzel T, Nicolay NH, Debus J, Rief H.

Radiat Oncol. 2018 Oct 30;13(1):212. doi: 10.1186/s13014-018-1161-4.

43.

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Adeberg S, Harrabi SB, Bougatf N, Verma V, Windisch P, Bernhardt D, Combs SE, Herfarth K, Debus J, Rieken S.

Cancers (Basel). 2018 Oct 26;10(11). pii: E401. doi: 10.3390/cancers10110401.

44.

Toxicity of radiation and immunotherapy combinations.

Verma V, Cushman TR, Tang C, Welsh JW.

Adv Radiat Oncol. 2018 Oct 23;3(4):506-511. doi: 10.1016/j.adro.2018.08.003. eCollection 2018 Oct-Dec. Review.

45.

Convenient and ultra-sensitive fluorescence detection of bovine serum albumin by using Rhodamine-6G modified gold nanoparticles in biological samples.

Verma VK, Tapadia K, Maharana T, Sharma A.

Luminescence. 2018 Dec;33(8):1408-1414. doi: 10.1002/bio.3563. Epub 2018 Oct 25.

PMID:
30362269
46.

Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.

Schonewolf CA, Heskel M, Doucette A, Singhal S, Frick MA, Xanthopoulos EP, Corradetti MN, Friedberg JS, Pechet TT, Christodouleas JP, Levin W, Berman A, Cengel KA, Verma V, Hahn SM, Kucharczuk JC, Rengan R, Simone CB 2nd.

Clin Lung Cancer. 2019 Jan;20(1):e63-e71. doi: 10.1016/j.cllc.2018.09.004. Epub 2018 Sep 20.

PMID:
30337269
47.

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy.

Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2018 Oct 4;10:4229-4235. doi: 10.2147/CMAR.S165956. eCollection 2018.

48.

Short-term glucose dysregulation following acute poisoning with organophosphorus insecticides but not herbicides, carbamate or pyrethroid insecticides in South Asia.

Gifford RM, Chathuranga U, Lamb T, Verma V, Sattar MA, Thompson A, Siribaddana S, Ghose A, Forbes S, Reynolds RM, Eddleston M.

Clin Toxicol (Phila). 2018 Oct 11:1-11. doi: 10.1080/15563650.2018.1515438. [Epub ahead of print] Erratum in: Clin Toxicol (Phila). 2018 Dec 11;:1.

PMID:
30306807
49.

Nanomedicine in cancer stem cell therapy: from fringe to forefront.

Tabassum N, Verma V, Kumar M, Kumar A, Singh B.

Cell Tissue Res. 2018 Dec;374(3):427-438. doi: 10.1007/s00441-018-2928-5. Epub 2018 Oct 9. Review.

PMID:
30302547
50.

Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.

Tucker SL, Xu T, Paganetti H, Deist T, Verma V, Choi N, Mohan R, Liao Z.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):403-410. doi: 10.1016/j.ijrobp.2018.09.029. Epub 2018 Oct 3.

PMID:
30291994

Supplemental Content

Support Center